Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease
Clinical trial NCT05007678 · COMPLETED
Trial details
- NCT number
- NCT05007678
- Sponsor
- Ashford and St. Peter's Hospitals NHS Trust
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2022-07-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.